Village Farms (VFF) Q2 2026 Earnings Call Transcript
Village Farms International (VFF) reported Q2 2026 consolidated net sales of $64 million, up 7% year over year, driven by international medical cannabis exports. Net income was $7.2 million, or $0.06 per share. Adjusted EBITDA was $15.4 million. International export sales rose 74% to $20.9 million, with Germany a key driver.
How this was made
The 30-second read
Why it matters
Traders can update expectations for VFF’s earnings trajectory using the reported Q2 financials, cannabis gross margin expansion drivers, and specific production conversion and capacity timelines (Delta 2 conversion Sept. 1; Groningen full capacity by end of Q1 2027).
Market read
The call provides actionable, company-specific earnings and operational metrics that can drive near-term trading around VFF’s growth and margin outlook.
What to watch
SG&A rose on transfer pricing and commercial costs, and excise taxes in Canada ($15M) remain a meaningful drag that could offset gains if demand softens.
Background
Village Farms International held its Q2 2026 earnings call, reporting results and operational updates across cannabis exports, Delta campus expansion, and Netherlands Phase II ramp.
Ticker impact
Village Farms reported Q2 2026 results, including $64M net sales, $7.2M net income, and 74% YoY growth in international medical cannabis exports.
Moderately positive bias, with traders likely focusing on export growth durability, margin sustainability, and the Sept. 1 Delta 2 conversion schedule.
The article contains multiple new, company-specific datapoints from the earnings call (sales, income, EBITDA, gross margin drivers, and concrete production/capacity milestones) that can change short-term valuation expectations.
Market effects
Highlights ongoing demand for EU GMP pharmaceutical-grade cannabis and the importance of compliance and product certification in Germany pricing.
Emphasizes Germany as the key growth engine and the Netherlands Groningen ramp as a new supply contributor into 2027.
Reinforces that international medical cannabis export growth and regulatory/compliance dynamics are central to cross-border cannabis producers’ earnings power.
Counterpoint
Export growth and margin expansion may be partly mix-driven and could reverse if Germany pricing weakens due to more non-certified product supply.
Key entities
- public_companyVillage Farms International, Inc.
Subject of the earnings call transcript, reporting Q2 2026 financial results and capacity/market updates.
- executiveMichael DeGiglio
CEO who discussed Germany market growth and compliance-related product flow affecting pricing.
- executiveSteve Ruffini
CFO who commented on cash/escrow changes and financial positioning.
- executiveAnn Gillin Lefever
COO who provided operational context, including market testing and greenwashing crackdowns.
